NewsRamp Editorial Team
NewsRamp
@newsramp
NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
2325 articles
Articles
Accentro Real Estate AG Restructuring Plan Implementation FAQ
What is the main announcement in this content? Accentro Real Estate AG has successfully implemented all measures of its restructuring plan that was confirmed by the Local Court Charlottenburg on September 23, 2025 under the German Corporate Stabilization and Restructuring Act (StaRUG). Why is this restructuring implementati...
November 13, 2025Read more
FAQ: October 2025 Biohacking Index Report and Top Wellness Brands
What is the October 2025 Biohacking Index Report? The October 2025 Biohacking Index Report is a comprehensive analysis released by Wellness Eternal that identifies the top 10 high-growth wellness and longevity brands based on verified reviews and data-backed transparency. Who created and collaborated on this report? The rep...
November 13, 2025Read more
Valens Semiconductor Q3 2025 Financial Results and Business Update FAQ
What were Valens Semiconductor's key financial results for Q3 2025? Valens reported Q3 2025 revenue of $17.3M, significantly above guidance of $15.1–$15.6M, marking the sixth consecutive quarter of growth. GAAP gross margin was 63.0% and adjusted EBITDA loss was $(4.3)M, better than the expected $(7.4)–$(6.8)M range. How di...
November 13, 2025Read more
FAQ: Stonegate Capital Partners' Coverage Update on Burcon Nutrascience Corporation (TSX: BU) Q2 FY26
What is the main focus of Stonegate Capital Partners' update on Burcon Nutrascience? The update focuses on Burcon's commercialization progress across multiple plant proteins, including Puratein® C canola protein, FavaPro™ fava protein, and Peazazz® C pea protein, along with recent financing activities and financial performa...
November 13, 2025Read more
FAQ: Go Find Joy Book and PEMF Therapy for Anxiety Relief
"Go Find Joy: The Science of Calm" Introduces PEMF Technology as Drug-Free Alternative for Anxiety Management
November 13, 2025Read more
GeoVax Q3 2025 Financial Results and Business Update FAQ
What is the main focus of GeoVax's business update for Q3 2025? The update highlights progress across GeoVax's vaccine and oncology programs, including accelerated development of GEO-MVA for Mpox, strong clinical data for GEO-CM04S1 COVID-19 vaccine in immunocompromised patients, and expansion of Gedeptin® into new solid tu...
November 13, 2025Read more
FAQ: Trilogy Metals Inc. as a Key Source of Critical Minerals
What is Trilogy Metals Inc. and what does it do? Trilogy Metals is a metal exploration and development company that holds a 50% interest in Ambler Metals LLC, which owns the Upper Kobuk Mineral Projects in northwestern Alaska. Why is Trilogy Metals considered important for national security and critical minerals? The compan...
November 13, 2025Read more
Datavault AI Dream Bowl Draft Meme Dividend FAQ
What is the Dream Bowl Draft Meme Coin dividend? The Dream Bowl Draft Meme Coin is a property-classified digital asset dividend from Datavault AI that provides shareholders with verifiable ownership, authenticated data access, event privileges, and engagement through the company's patented verification platform. How is this...
November 13, 2025Read more
FAQ: Rooted Wellness Retreats 6-Day Functional Medicine Immersion in Kona, Hawaii
Rooted Wellness Retreats opens applications for its 6-day functional medicine immersion in Kona, Hawaii, February 26–March 3, 2026. Designed for just 12 participants, the retreat offers personalized care, nourishing meals, and real transformation — body, mind, and spirit.
November 13, 2025Read more
FAQ: Fairchild Gold Corp.'s Golden Arrow Project Acquisition and Strategic Positioning
What is the main announcement from Fairchild Gold Corp.? Fairchild Gold Corp. announced a memorandum of understanding to acquire the Golden Arrow Project in Nevada's Walker Lane Belt for US$5 million, which adds 420,000 ounces of historic gold resources and expands its Nevada landholding by 170%. Where is the Golden Arrow P...
November 13, 2025Read more
FAQ: Strawberry Fields REIT's Expansion in the Elderly Care Market
What is Strawberry Fields REIT and what does it do? Strawberry Fields REIT is a self-administered real estate investment trust that owns, acquires, develops, and leases skilled nursing facilities and other healthcare-related properties. Why is the elderly care market considered a significant opportunity? The elderly care ma...
November 13, 2025Read more
FAQ: inCruises Record Growth and Global Convention Announcement
What is the main announcement in this content? inCruises reported record growth with 7,494 new Partners in September 2025 - the highest monthly total in two years - and announced The Global Convention, their first worldwide meeting of Partners and Members scheduled for September 2026 in Belgrade, Serbia. Why is this growth ...
November 13, 2025Read more
FAQ: Micropolis Holding Co.'s NVIDIA Partnership and AI-Driven Robotics
What is the main announcement in this content? Micropolis Holding Co. announced its membership in NVIDIA's Inception Program, a strategic collaboration that integrates NVIDIA's GPU and simulation technologies into Micropolis's robotics ecosystem for enhanced autonomous platform performance. Why is this partnership with NVID...
November 13, 2025Read more
FAQ: NanoViricides $6 Million Registered Direct Offering and Corporate Overview
What is the main announcement in this content? NanoViricides has closed a $6 million registered direct offering of 3,571,429 shares at $1.68 per share with a healthcare institutional investor, along with concurrent private placement of Series A and Series B warrants. How will NanoViricides use the proceeds from this offerin...
November 13, 2025Read more
FAQ: HeartBeam's Remote Cardiac Diagnostics Partnership with HeartNexus
What is the main purpose of HeartBeam's partnership with HeartNexus? The partnership aims to expand access to cardiologist-level ECG insights for arrhythmia assessment anytime, anywhere by making board-certified cardiologists available 24/7 to interpret results from HeartBeam's portable ECG system. How does the HeartBeam Sy...
November 13, 2025Read more
FAQ: Canada's G7 Critical Minerals Alliance Projects and Nouveau Monde Graphite's Role
What is the G7 Critical Minerals Alliance and what shift has occurred? The G7 Critical Minerals Alliance represents a pivot from 'resilience' to a full-fledged alliance where Western governments are no longer just acknowledging supply chain risks but are actively co-investing and partnering with industry to secure critical ...
November 13, 2025Read more
FAQ: SuperCom Ltd. Q3 and Nine-Month 2025 Financial Results and Business Momentum
What were SuperCom's key financial results for the nine months ended September 30, 2025? SuperCom reported nine-month revenue of $20.4 million, gross profit of $12.5 million with gross margin expanding to 61% from 50.1%, operating income nearly tripled to $3 million, net income more than doubled to $6 million, and EBITDA in...
November 13, 2025Read more
FAQ: SuperCom Ltd. Q3 and Nine-Month 2025 Financial Results and Global Expansion
What were SuperCom's key financial results for the nine months ended September 30, 2025? For the nine months ended September 30, 2025, SuperCom reported revenue of $20.4 million, gross profit of $12.5 million with gross margin expanding to 61% from 50.1%, operating income nearly tripled to $3 million, net income more than d...
November 13, 2025Read more
FAQ: Cybin Inc. Q2 2025 Results and Neuropsychiatry Program Updates
What are the key highlights from Cybin's Q2 2025 results? Cybin reported strong institutional demand for its completed financing and advanced multiple clinical programs, including completing enrollment in the Phase 2 CYB004 study for GAD and progressing CYB003 through Phase 3 trials for MDD treatment. What clinical programs...
November 13, 2025Read more
FAQ: SuperCom's Alabama Electronic Monitoring Expansion and U.S. Market Growth
What is the main announcement from SuperCom? SuperCom has secured two new electronic monitoring service provider contracts in Alabama, marking their third and fourth deployments in the state within less than a year. What technology does SuperCom use for electronic monitoring? SuperCom uses its proprietary PureSecurity™ plat...
November 13, 2025Read more
Lantern Pharma Q3 2025 Results and AI-Driven Oncology Pipeline FAQ
What were the key highlights from Lantern Pharma's Q3 2025 results? Lantern Pharma reported completion of enrollment and achievement of all primary endpoints in the LP-184 Phase 1a trial, showing a 48% clinical benefit rate at or above the therapeutic dose threshold with favorable safety profile and strong biomarker correla...
November 13, 2025Read more